Infinity Pharmaceuticals Inc. (INFIQ)

Infinity Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019
Cash & Equivalents	38.31	80.73	28.59	22.26
Short-Term Investments	-	-	5.52	20.18
Cash & Cash Equivalents	38.31	80.73	34.11	-
Cash Growth	-52.54%	136.68%	-	-
Other Current Assets	1.99	1.54	1.91	-
Total Current Assets	40.3	82.27	36.02	44.58
Property, Plant & Equipment	3.06	3.41	3.76	-
Other Long-Term Assets	-1.22	-0.9	-0.46	-
Total Long-Term Assets	1.85	2.52	3.3	4.43
Total Assets	42.15	84.79	39.32	49.01
Accounts Payable	4.41	2.32	2.98	1.62
Current Debt	0.59	0.52	0.49	0.38
Other Current Liabilities	8.63	10.46	7.58	-
Total Current Liabilities	13.63	13.3	11.05	9.7
Long-Term Debt	0.32	0.92	23	1.93
Other Long-Term Liabilities	47.25	49	28.27	-
Total Long-Term Liabilities	47.57	49.91	51.26	31.59
Total Liabilities	61.2	63.21	62.31	41.29
Total Debt	0.92	1.44	23.48	-
Debt Growth	-36.14%	-93.89%	-	-
Common Stock	0.09	0.09	0.06	0.06
Retained Earnings	-855.95	-811.58	-766.32	-725.83
Shareholders' Equity	-19.05	21.57	-22.99	7.73
Net Cash / Debt	37.4	79.29	10.62	-
Net Cash / Debt Growth	-52.84%	646.33%	-	-
Net Cash Per Share	0.42	0.93	0.18	-
Working Capital	26.67	68.97	24.97	-
Book Value Per Share	-0.21	0.25	-0.38	-